SUBLICENSE AGREEMENTSublicense Agreement • May 5th, 2020 • New Jersey
SUBLICENSE AGREEMENTSublicense Agreement • July 3rd, 2017 • PowerShares Exchange-Traded Fund Trust II • Illinois
This Sublicense Agreement (“AGREEMENT”) is entered into as of by and between Invesco PowerShares Capital Management, LLC, a Delaware corporation with offices at 3500 Lacey Road, Suite 700, Downers Grove, IL 60515 (“POWERSHARES”), and PowerShares Exchange-Traded Fund Trust II (“LICENSEE”).
SUBLICENSE AGREEMENTSublicense Agreement • August 19th, 2022 • Exchange Traded Concepts Trust • Delaware
This Sublicense Agreement (“Agreement”) is made as of July 6, 2022, by and between Exchange Traded Concepts, LLC, a registered investment adviser (“Adviser”) and Exchange Traded Concepts Trust, a Delaware statutory trust (“Trust”).
SUBLICENSE AGREEMENTSublicense Agreement • November 25th, 2013 • First Trust Exchange-Traded Alphadex Fund • New York
SUBLICENSE AGREEMENTSublicense Agreement • June 1st, 2011 • Currencyshares Chinese Renminbi Trust • Maryland
This Sublicense Agreement (this “Agreement”) is entered into as of [June 1], 2011 (the “Effective Date”), by and between Security Investors, LLC, a Kansas limited liability company (“Licensor”), and Rydex Specialized Products LLC, a Delaware limited liability company wholly-owned by Licensor (“Licensee”).
SUBLICENSE AGREEMENTSublicense Agreement • April 27th, 2007 • First Trust Exchange-Traded Alphadex Fund • New York
SUBLICENSE AGREEMENTSublicense Agreement • April 11th, 2014 • PowerShares Exchange-Traded Fund Trust II • Illinois
This Sublicense Agreement (“AGREEMENT”) is entered into as of by and between Invesco PowerShares Capital Management, LLC, a Delaware corporation with offices at 3500 Lacey Road, Suite 700, Downers Grove, IL 60515 (“POWERSHARES”), and PowerShares Exchange-Traded Fund Trust II (“LICENSEE”).
SUBLICENSE AGREEMENT ForSublicense Agreement • April 1st, 2024
AMENDED AND RESTATED SUBLICENSE AGREEMENTSublicense Agreement • November 7th, 2017 • Keryx Biopharmaceuticals Inc • Pharmaceutical preparations • New York
THIS AMENDED AND RESTATED SUBLICENSE AGREEMENT (the “Agreement”), effective this 8th day of June, 2009 (the “Effective Date”), by and between KERYX BIOPHARMACEUTICALS, INC., with offices at 750 Lexington Avenue, 20th Floor, New York, NY 10022, U.S.A. (“Keryx” or “Sublicensor”) and JAPAN TOBACCO INC., with offices at JT Building, 2-1, Toranomon 2-Chome, Minato-ku, Tokyo 105-8422, Japan (“JT”) and TORII PHARMACEUTICAL CO., LTD., with offices at Torii Nihonbashi Bldg., 4-1, Nihonbashi-Honcho 3-chome, Chuo-ku, Tokyo 103-8439, Japan (“TORII”) (JT and TORII collectively referred to herein as “Sublicensee”);
Exhibit (h.11) AMENDMENT TO SUBLICENSE AGREEMENT This Amendment to the Sublicense Agreement dated March 18, 2000 (the "Agreement") between BlackRock Institutional Trust Company, N.A. ("BTC"), a national banking association, and iShares, Inc....Sublicense Agreement • May 3rd, 2010 • iSHARES INC
This Amendment to the Sublicense Agreement dated March 18, 2000 (the "Agreement") between BlackRock Institutional Trust Company, N.A. ("BTC"), a national banking association, and iShares, Inc. ("iShares"), a Maryland corporation, is effective as of April 29, 2010.
SUBLICENSE AGREEMENT TO USE SARASOTA MAJOR/MINOR LEAGUE PROPERTYSublicense Agreement • December 11th, 2013 • Florida
As Party of the Second Part, hereinafter called Licensee. The Licensor and the Licensee may be referred to herein as a “party” and collectively, as the “parties.”
EX-10.21 28 d480882dex1021.htm EX-10.21 [***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential Treatment has been requested with respect to the omitted portions....Sublicense Agreement • May 5th, 2020 • New York
This SUBLICENSE AGREEMENT (this “Agreement”), effective as of July 29, 2015 (the “Effective Date”), is by and between MEREO BIOPHARMA 3 LIMITED, a private limited company incorporated in England and Wales (“Buyer”) and a wholly owned subsidiary of MEREO BIOPHARMA GROUP LIMITED, a company incorporated in England and Wales (“Mereo”), and NOVARTIS PHARMA AG, a Swiss company (“Novartis”).
Exhibit (h.15) AMENDMENT TO SUBLICENSE AGREEMENT This Amendment to the Sublicense Agreement dated April 25, 2000 (the "Agreement") between Barclays Global Investors, N.A. ("BGI"), a national banking association, and iShares Trust ("iShares"), a...Sublicense Agreement • July 29th, 2008 • iSHARES TRUST
This Amendment to the Sublicense Agreement dated April 25, 2000 (the "Agreement") between Barclays Global Investors, N.A. ("BGI"), a national banking association, and iShares Trust ("iShares"), a Delaware statutory trust, is effective as of June 19, 2008.
SUBLICENSE AGREEMENTSublicense Agreement • January 21st, 2009 • Impax Laboratories Inc • Pharmaceutical preparations
This Sublicense Agreement (the “Agreement”), effective as of March 30, 2007 (the “Effective Date”), is by and between DAVA Pharmaceuticals, Inc., a Delaware corporation (“DAVA”), and IMPAX Laboratories, Inc., a Delaware corporation (“IMPAX”).
SUBLICENSE AGREEMENTSublicense Agreement • August 19th, 2016 • Checkpoint Therapeutics, Inc. • Pharmaceutical preparations • New York
THIS SUBLICENSE AGREEMENT (the “Agreement”) is dated as of May 26, 2016 (the “Effective Date”) by and between Checkpoint Therapeutics, Inc, a Delaware corporation with its place of business at 2 Gansevoort Street, 9th Floor, New York, New York 10014 (“Checkpoint”), and TG Therapeutics, Inc, Inc., a Delaware corporation with its place of business at 2 Gansevoort Street, 9th Floor, New York, New York 10014 (“TGTX”). Checkpoint, on the one hand, and TGTX, on the other hand, shall each be referred to herein as a “Party” or, collectively, as the “Parties.”
SUBLICENSE AGREEMENTSublicense Agreement • February 23rd, 2023 • iShares U.S. ETF Trust
This Sublicense Agreement (the “Agreement”) is made as of November 7, 2022, by and between BlackRock Fund Advisors (“BFA”), a California corporation, and iShares Trust and iShares U.S. ETF Trust, each a statutory trust established under the laws of the State of Delaware, and iShares, Inc., a Maryland corporation (together with iShares Trust and iShares U.S. ETF Trust, the “Registrants”).
SUBLICENSE AGREEMENTSublicense Agreement • August 23rd, 2019 • Impact Shares Trust I • Texas
This Sublicense Agreement (the “AGREEMENT”) is entered into as of July 17, 2018, by and between Impact Shares, Corp., a Texas non-profit corporation (“Impact Shares”) with offices at 2189 Broken Bend, Frisco, Texas 75034 (the “ADVISER”), and Impact Shares Trust I (the “LICENSEE”).
between 1ST ACCREDITED VENTURE CAPITAL LLLP and E-SITE TECHNOLOGIES, INC. SUBLICENSE AGREEMENTSublicense Agreement • April 5th, 2002 • Online Holdings Inc • Blank checks • Colorado
THIS AGREEMENT (the "Agreement" or "License Agreement") is dated June 26, 2001 between 1st Accredited Venture Capital LLLP, a limited liability limited partnership ("1st Accredited") and E-Site Technologies, Inc., a Colorado corporation ("E-Site").
SUBLICENSE AGREEMENTSublicense Agreement • December 21st, 2022 • iShares, Inc.
This Sublicense Agreement (the “Agreement”) is made as of October 19, 2022, by and between BlackRock Fund Advisors (“BFA”), a California corporation, and iShares Trust and iShares U.S. ETF Trust, each a statutory trust established under the laws of the State of Delaware, and iShares, Inc., a Maryland corporation (together with iShares Trust and iShares U.S. ETF Trust, the “Registrants”).
EXHIBIT II SUBLICENSE AGREEMENTSublicense Agreement • November 26th, 2007 • FocusShares Trust
This Sublicense Agreement (the “Sublicense Agreement”), dated as of the 8th of June, 2007, and restated on the 16th of November, 2007 is made by and among FocusSharesTrust (the “Sub-licensee”), International Securities Exchange, LLC (“Licensor”), and Licensee (“Licensee” or “Sub-licensor”).
EX-10.27 53 dex1027.htm EXCLUSIVE SUBLICENSE AGREEMENT / NOVARTIS AG EXCLUSIVE SUBLICENSE AGREEMENT BETWEEN RELIANT PHARMACEUTICALS, LLC AND NOVARTIS AG SUBLICENSE AGREEMENTSublicense Agreement • May 5th, 2020 • New Jersey
THIS SUBLICENSE AGREEMENT (this “Agreement”) dated as of the 11th day of March, 2003, by and between Novartis AG, a company incorporated under the laws of Switzerland, with a principal place of business located at Postfach 4002, Basel, Switzerland (hereinafter “Novartis”) and Reliant Pharmaceuticals, LLC, a Delaware limited liability company, with its principal place of business at 110 Allen Road, Liberty Corner, New Jersey 07938 (“Reliant”).
SUBLICENSE AGREEMENTSublicense Agreement • December 21st, 2022 • iShares, Inc.
This Sublicense Agreement (the “Agreement”) is made as of October 19, 2022, by and between BlackRock Fund Advisors (“BFA”), a California corporation, and iShares Trust and iShares U.S. ETF Trust, each a statutory trust established under the laws of the State of Delaware, and iShares, Inc., a Maryland corporation (together with iShares Trust and iShares U.S. ETF Trust, the “Registrants”).
= CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED BECAUSE THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. CONFIDENTIAL Execution Version SUBLICENSE...Sublicense Agreement • May 5th, 2020 • New York
This Sublicense Agreement (the “Agreement”) is made and entered into as of April 16th, 2018, by and between 89Bio, Ltd. a company organized under the laws of Israel (“Company”), and ratiopharm GmbH company a company organized under the laws of Germany (“Teva”). This Sublicense Agreement shall become effective upon the closing of the Asset Purchase Agreement, as defined below, (the “Effective Date”).
SUBLICENSE AGREEMENTSublicense Agreement • February 8th, 2008 • MAKO Surgical Corp. • Orthopedic, prosthetic & surgical appliances & supplies • Massachusetts
This Sublicense Agreement (the “Agreement”), effective as of May 24th, 2006 (“Effective Date”) is made by and between SensAble Technologies, Inc. (“SensAble”), a Delaware corporation, having offices at 15 Constitution Way, Woburn, MA 01801, and MAKO Surgical Corp. (“MAKO”), a Delaware corporation with offices at 2901 Simms St., Hollywood, FL 33020. SensAble and MAKO are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
SUBLICENSE AGREEMENTSublicense Agreement • August 7th, 2013 • Arizona
THIS LICENSE AGREEMENT (the “Agreement”) is entered into and effective this day of , 20_ , by and between Safari Club International, an Arizona non-profit corporation (“SCI”), and , a
SUBLICENSE AGREEMENTSublicense Agreement • December 21st, 2022 • iShares, Inc.
This Sublicense Agreement (the “Agreement”) is made as of October 19, 2022, by and between BlackRock Fund Advisors (“BFA”), a California corporation, and iShares Trust and iShares U.S. ETF Trust, each a statutory trust established under the laws of the State of Delaware, and iShares, Inc., a Maryland corporation (together with iShares Trust and iShares U.S. ETF Trust, the “Registrants”).
EX-10.07 12 ex10-07.htm Execution Version CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY “[***],” HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24B-2 OF THE SECURITIES...Sublicense Agreement • May 5th, 2020 • California
THIS SUBLICENSE Agreement (“Agreement”) is entered into on September 26, 2017 (the “Effective Date”) by and between BIOTIME, INC., a California corporation, having its principal place of business at 1010 Atlantic Avenue, Suite 102, Alameda, CA 94501 (“BioTime”), and AGEX THERAPEUTICS, INC., a Delaware corporation, having its principal place of business at 1010 Atlantic Avenue, Suite 102, Alameda, CA 94501 (“AgeX”).
SUBLICENSE AGREEMENTSublicense Agreement • December 21st, 2022 • iShares, Inc.
This Sublicense Agreement (the “Agreement”) is made as of October 19, 2022, by and between BlackRock Fund Advisors (“BFA”), a California corporation, and iShares Trust and iShares U.S. ETF Trust, each a statutory trust established under the laws of the State of Delaware, and iShares, Inc., a Maryland corporation (together with iShares Trust and iShares U.S. ETF Trust, the “Registrants”).
AMENDED AND RESTATED SUBLICENSE AGREEMENTSublicense Agreement • August 7th, 2017 • iSHARES TRUST • California
This Amended and Restated Sublicense Agreement (the “Agreement”) is made as of September 23, 2015, by and between BlackRock Fund Advisors (“BFA”), a California corporation and iShares Trust (the “Trust”), a statutory trust established under the laws of the State of Delaware, and iShares, Inc. (the “Company”), a company established under the laws of the State of Maryland (the Trust and the Company together, the “Companies”).
EXHIBIT 4.8 REFERENCE PRICE SUBLICENSING AGREEMENT THIS SUBLICENSE AGREEMENT (the "Sublicense Agreement") is entered into as of November 22, 2006 ("Effective Date"), by and among MACROMARKETS LLC, a Delaware limited liability company ("Sublicensor"),...Sublicense Agreement • May 30th, 2008 • MACROshares Oil Down Holding Trust • Asset-backed securities • New York
SUBLICENSE AGREEMENTSublicense Agreement • February 23rd, 2023 • iShares U.S. ETF Trust
This Sublicense Agreement (the “Agreement”) is made as of November 7, 2022, by and between BlackRock Fund Advisors (“BFA”), a California corporation, and iShares Trust and iShares U.S. ETF Trust, each a statutory trust established under the laws of the State of Delaware, and iShares, Inc., a Maryland corporation (together with iShares Trust and iShares U.S. ETF Trust, the “Registrants”).
SUBLICENSE AGREEMENTSublicense Agreement • October 21st, 2024 • iSHARES TRUST
This Sublicense Agreement (the “Agreement”) is made as of October 18, 2024, by and between BlackRock Fund Advisors (“BFA”), a California corporation, and iShares Trust and iShares U.S. ETF Trust, each a statutory trust established under the laws of the State of Delaware, and iShares, Inc., a Maryland corporation (together with iShares Trust and iShares U.S. ETF Trust, the “Registrants”).
Exhibit (h.22) AMENDMENT TO SUBLICENSE AGREEMENT This Amendment to the Sublicense Agreement dated March 18, 2000 (the "Agreement") between Barclays Global Investors, N.A. ("BGI"), a national banking association, and iShares Trust ("iShares"), a...Sublicense Agreement • November 20th, 2008 • iSHARES TRUST
This Amendment to the Sublicense Agreement dated March 18, 2000 (the "Agreement") between Barclays Global Investors, N.A. ("BGI"), a national banking association, and iShares Trust ("iShares"), a Delaware statutory trust, is effective as of November 12, 2008.
SUBLICENSE AGREEMENTSublicense Agreement • January 30th, 2014 • CBD Energy LTD • Semiconductors & related devices • New York
This sublicense agreement (“Sublicense Agreement”) commences on the Effective Date and is made by and between (i) Westinghouse Electric Corporation, a Delaware corporation, having its principal place of business at 51 West 52nd Street, New York, NY 10019 (hereinafter referred to as “Westinghouse”); (ii) Westinghouse Solar, Inc., a Delaware corporation, having its principal place of business at 1475 S. Bascom Ave., Suite 101, Campbell, CA 95008 (“W- Solar”) and Andalay Solar Inc., (“Andalay”) a wholly owned subsidiary of W-Solar (hereinafter W-Solar and Andalay each referred to as a “Sublicensor” and collectively referred to as the “Sublicensors”); (iii) and CBD Energy Limited (ACN 010 966 973), an Australia company, having its principal place of business at 53 Cross Street Double Bay, Suite 2 — Level 2, Sydney NSW Australia 2028 (hereinafter referred to as the “Sublicensee”).
SUBLICENSE AGREEMENT BETWEEN VERTEX PHARMACEUTICALS INCORPORATED AND ENTRADA THERAPEUTICS, INC. December 7, 2022Sublicense Agreement • March 13th, 2024 • Entrada Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
This Sublicense Agreement (this “Agreement”) is entered into as of December 7, 2022 (the “Execution Date”) by and between Vertex Pharmaceuticals Incorporated, a corporation organized under the laws of The Commonwealth of Massachusetts (“Vertex”), and Entrada Therapeutics, Inc., a corporation organized under the laws of the State of Delaware (“Company”). Vertex and Company each may be referred to herein individually as a “Party” or collectively as the “Parties.”
